Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ultrasound dye could spot ovarian emergencies faster

NCT ID NCT04522219

Diagnosis Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether using a contrast dye during ultrasound can help doctors more accurately diagnose adnexal torsion (twisted ovary), a painful emergency. The plan was to compare contrast-enhanced ultrasound to standard ultrasound in women scheduled for surgery. However, the study was stopped early after only 11 participants, so the findings are very limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SonoVue® (contrast agent)
What this could lead to
If successful, this could provide a faster, more accurate way to diagnose adnexal torsion in emergency settings.
What could go wrong
The study was terminated early with very few participants, so results are limited and may not be reliable. Contrast agents also carry risks for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

11 people

The number who actually took part.

Started

Apr 2021

Finished

Jun 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Woman over 18 years old * Woman affiliated to a social security * Woman having received complete information on the organization of the research and having given her informed consent in written form. * Planned surgical intervention for suspected adnexal torsion Exclusion Criteria: * Patients under a measure of legal protection, * Contraindication to contrast injection Hypersensitivity to sulfur hexafluoride or any of the other ingredients, history of cardiac disease, respiratory distress syndrome, severe pulmonary hypertension..

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adnexal torsion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Ovarian Torsion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adnexal torsion

Contacts and locations

Locations

  • Centre Hospitalier Régional Universitaire de Nancy

    Nancy, 54000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.